We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Obesity-Related Complications Including Dysglycemia Based on 1-h Post-Load Plasma Glucose in Children and Adolescents Screened before and after COVID-19 Pandemic.
- Authors
Smyczyńska, Joanna; Olejniczak, Aleksandra; Różycka, Paulina; Chylińska-Frątczak, Aneta; Michalak, Arkadiusz; Smyczyńska, Urszula; Mianowska, Beata; Pietrzak, Iwona; Szadkowska, Agnieszka
- Abstract
Childhood obesity, with its metabolic complications, is a problem of public health. The International Diabetes Federation (IDF) has recommended glucose levels 1 h post oral glucose load (1h-PG) > 155–209 mg/dL as diagnostic for intermediate hyperglycemia (IH), while >209 mg/dL for type 2 diabetes (T2D). The aim of the study was to assess the occurrence of prediabetes, IH, and T2D in children and adolescents with simple obesity according to the criteria of American Diabetes Association (ADA) and of IDF, and the effect of COVID-19 pandemic on these disorders. Analysis included 263 children with simple obesity, screened either in prepandemic (PRE—113 cases) or post-pandemic period (POST—150 cases). All children underwent 2 h OGTT with measurements of glucose and insulin every 0.5 h, lipid profile, and other tests; indices if insulin resistance (IR): HOMA, QUICKI, Matsuda index, AUC (glu/ins) were calculated. The incidence of T2D, prediabetes, and IH was higher in POST with respect to PRE, with significant differences in the indices of IR, except for HOMA. Significant differences were observed in the assessed parameters of glucose metabolism among the groups with T2D, prediabetes, IH, and normal glucose tolerance (NGT), with some similarities between IH (based on 1h-PG) and prediabetes. Increased frequency of dysglycemia among children and adolescents with simple obesity is observed after COVID-19 pandemic. Metabolic profile of patients with IH at 1h-PG is "intermediate" between NGT and prediabetes.
- Subjects
PREDIABETIC state; RISK assessment; GLUCOSE tolerance tests; BLOOD sugar; HYPERGLYCEMIA; INSULIN resistance; TYPE 2 diabetes; CHILDHOOD obesity; MEDICAL screening; ENDOCRINE diseases; COVID-19 pandemic; BLOOD sugar monitoring; DISEASE risk factors; DISEASE complications; ADOLESCENCE; CHILDREN
- Publication
Nutrients, 2024, Vol 16, Issue 15, p2568
- ISSN
2072-6643
- Publication type
Article
- DOI
10.3390/nu16152568